Patents by Inventor Samuel Cheshier

Samuel Cheshier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of pediatric brain tumors with targeting of CD47 pathway
    Patent number: 11078272
    Abstract: Methods are provided for targeting pediatric brain tumor cells for depletion.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 3, 2021
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Sharareh Gholamin, Samuel Cheshier, Siddhartha S. Mitra, Irving L. Weissman
  • TREATMENT OF PEDIATRIC BRAIN TUMORS WITH TARGETING OF CD47 PATHWAY
    Publication number: 20180258170
    Abstract: Methods are provided for targeting pediatric brain tumor cells for depletion.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Inventors: Sharareh Gholamin, Samuel Cheshier, Siddhartha S. Mitra, Irving L. Weissman
  • SELF-RENEWAL OF NEURAL STEM CELLS IS PROMOTED BY WNT PROTEINS
    Publication number: 20080213892
    Abstract: Mammalian neural progenitor or stem cells are expanded in vitro by culture in the presence of one or more wnt polypeptides. The expanded cells substantially maintain their original phenotype including the ability to give rise to multiple types of differentiated cells.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 4, 2008
    Inventors: Roeland Nusse, M. Yashar S. Kalani, Samuel Cheshier